-
2 Berichten
-
1 foto's
-
0 Video’s
-
SEO bij DengyueMed
-
Woont in HongKong
-
Vanaf hongkong
-
Studie medicine bij guangdongyaokedaxueClass of gvsg
-
Female
-
Gevolgd door 0 people
Actueel
-
How does the IL-17A inhibitor secukinumab (Cosentyx) change the rules of inflammation management?In the field of immune-mediated inflammatory disease (IMID) treatment, the advent of biologic therapies has broken the limitations of traditional approaches and brought renewed hope for recovery to countless patients. As the world’s first fully human monoclonal antibody targeting interleukin-17A (IL-17A) to receive regulatory approval, secukinumab (Cosentyx) injection has demonstrated...0 Reacties 0 aandelen 165 Views 0 voorbeeldPlease log in to like, share and comment!
-
0 Reacties 0 aandelen 78 Views 0 voorbeeld
Meer blogs